Infectious Disease Doctors in Palm Beach Gardens, FL Accepting Medicare

2 Infectious Disease doctors found. Showing 1 - 2

Dr. Andres Enrique Suarez, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 11211 Prosperity Farms Rd, Suite B-105, Palm Beach Gardens, FL 33410 Phone: 561-626-2914    Fax: 561-626-2915

Dr. Daniel Eric Peters, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 11211 Prosperity Farms Rd, Suite B-105, Palm Beach Gardens, FL 33410 Phone: 561-626-2914    Fax: 561-626-2915

News Archive

Severe COVID-19 linked to age, body mass index and ABO blood group

With the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecting over 50 million people worldwide with hundreds of thousands experiencing severe respiratory illness, researchers have been trying to find the factors associated with severe disease. From the start of the pandemic in March this year, several studies have indicated heart disease, high blood pressure, diabetes, obesity, etc. could be linked to severe disease. Now German researchers have published a study on the association between severe respiratory infection caused by SARS CoV-2 and factors such as age, body mass index (BMI) and ABO blood group.

PTSD not associated with increased risk for cancer, find BUSM researchers

In the largest study to date that examines Post Traumatic Stress Disorder (PTSD) as a risk factor for cancer, researchers from Boston University School of Medicine, have shown no evidence of an association.

FDA approves gene test to detect spread of breast cancer into lymph nodes

Veridex, LLC, a Johnson & Johnson company, has announced U.S. Food and Drug Administration (FDA) approval of the first intra-operative and gene-based test to detect the spread of breast cancer into the lymph nodes.

Does genetics affect eating behaviors?

A new study adopted a biological approach to assess if food-related behaviors and food involvement have a genetic explanation.

Wilson Therapeutics' WTX101-201 Phase 2 clinical study to be presented at EASL annual meeting

Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26.

Read more Medical News

› Verified 4 days ago